Sandu Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 17.73 | 17.09 | 15.90 |
| Operating Expense | 16.79 | 16.64 | 14.99 |
| Net Profit | 0.50 | 0.17 | 0.59 |
| Net Profit Margin | 2.82 | 0.99 | 3.71 |
| Earning Per Share | 0.52 | 0.17 | 0.50 |
| EBIDTA | 0.91 | 0.43 | 1 |
| Effective Tax Rate | 22.11 | 17.78 | 23.08 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 17.73 |
| Operating Expense | 16.79 |
| Net Profit | 0.50 |
| Net Profit Margin | 2.82 |
| Earning Per Share | 0.52 |
| EBIDTA | 0.91 |
| Effective Tax Rate | 22.11 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 67.28 | 65.35 | 65.50 |
| Operating Expenses Annual | 64.98 | 62.86 | 62.63 |
| Operating Profit Annual | 2.72 | 2.82 | 2.96 |
| Interest Annual | 0.06 | 0.08 | 0.11 |
| Depreciation | 0.58 | 0.52 | 0.53 |
| Net Profit Annual | 1.46 | 1.52 | 1.59 |
| Tax Annual | 0.61 | 0.70 | 0.73 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 67.28 |
| Operating Expenses Annual | 64.98 |
| Operating Profit Annual | 2.72 |
| Interest Annual | 0.06 |
| Depreciation | 0.58 |
| Net Profit Annual | 1.46 |
| Tax Annual | 0.61 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 2.27 | 0.94 | 4.53 |
| Cash Flow from Operations | 0.76 | 0.22 | 0.95 |
| Cash Flow from Investing | -1.31 | 0.53 | -5.47 |
| Cash Flow from Financing | -0.72 | 0.58 | 0.93 |
| Cash Flow at the End | 1 | 2.27 | 0.94 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 2.27 |
| Cash Flow from Operations | 0.76 |
| Cash Flow from Investing | -1.31 |
| Cash Flow from Financing | -0.72 |
| Cash Flow at the End | 1 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 4.04 | 4.32 | 4.52 |
| PBIT Margin (%) | 3.18 | 3.52 | 3.71 |
| PBT Margin (%) | -49.58 | -40.47 | -30.02 |
| Net PROFIT Margin (%) | 2.17 | 2.33 | 2.43 |
| Return On Networth / Equity (%) | 3.66 | 4.56 | 6.13 |
| Return On Networth /Employed (%) | 5.33 | 6.89 | 9.37 |
| Return On Assets (%) | 3.65 | 4.02 | 4.54 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 1.68 | 1.73 | 1.87 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 4.04 |
| PBIT Margin (%) | 3.18 |
| PBT Margin (%) | -49.58 |
| Net PROFIT Margin (%) | 2.17 |
| Return On Networth / Equity (%) | 3.66 |
| Return On Networth /Employed (%) | 5.33 |
| Return On Assets (%) | 3.65 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 1.68 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 17.88 | 16.62 | 16.00 |
| Total Current Assets Annual | 22.30 | 25.54 | 23.65 |
| Non Current Assets Annual | 30.12 | 28.63 | 25.64 |
| Total Shareholders Funds Annual | 40.60 | 39.24 | 36.47 |
| Total Assets Annual | 52.42 | 54.17 | 49.28 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 17.88 |
| Total Current Assets Annual | 22.30 |
| Non Current Assets Annual | 30.12 |
| Total Shareholders Funds Annual | 40.60 |
| Total Assets Annual | 52.42 |
EPS (INR)
Expected
0.52
Reported
1.95
Surprise
275.00%
Jun 2024
EPS beaten by 275.00%
Mar 2024
EPS beaten by -5.56%
Dec 2023
EPS beaten by 1.64%
